Global PET (Positron Emission Tomography)-CT Imaging System Market Value Is Forecast To Reach By 2034 With CAGR

PET (Positron Emission Tomography)-CT Imaging System by Type (Fixed Type, Mobile Type), by Application (Infectious Diseases, Neurology, Oncology, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $935.2 million

CAGR: 4.6%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $935.2 million

CAGR: 4.6%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

PET (Positron Emission Tomography)-CT Imaging System Market Size | CAGR 4.6 Forecast 2033

Global PET (Positron Emission Tomography)-CT Imaging System Market Value Is Forecast To Reach By 2034 With CAGR

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $935.2 million

CAGR: 4.6%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $935.2 million

CAGR: 4.6%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

PET (Positron Emission Tomography)-CT Imaging System Market Overview

The PET (Positron Emission Tomography)-CT Imaging System market comprises hybrid diagnostic platforms that combine functional PET imaging with anatomical CT scanning, enabling precise disease detection and treatment monitoring. Executive-ready insights on PET-CT market size, growth outlook, market forecast, and industry expansion reveal a $3.3 billion valuation in the base year 2025, with a projected CAGR of 6.5% through 2033. The upward trajectory is propelled by rising cancer prevalence, expanding reimbursement frameworks, and accelerated adoption of precision‑medicine protocols across hospitals and imaging centers.

Loading chart…

Key forces shaping the PET-CT landscape include rapid technological convergence toward integrated and hybrid systems, tightening regulatory pathways that streamline approvals for novel radiotracers, and intensified competitive dynamics as major OEMs launch AI‑enhanced imaging suites. North America remains the largest market, driven by high healthcare spend and early technology adoption, while the Asia‑Pacific region is the fastest‑growing segment, buoyed by expanding diagnostic infrastructure and rising demand for oncology imaging in emerging economies.

Report Overview

Report Attribute	Details
Market size value in 2025	935.20 million
Revenue forecast in 2033	1.34 billion
Growth rate	CAGR of 4.6% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	United Imaging; GE Healthcare; Toshiba; Siemens Healthineers; Hitachi; Neusoft Medical Systems; MinFound Medical Systems; Philips Healthcare; Mediso; PINGSENG Healthcare; PerkinElmer; Kindsway Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The PET (Positron Emission Tomography)-CT Imaging System market is being reshaped by converging forces of clinical need, technological innovation, and policy evolution. As oncology and neurology diagnostics increasingly rely on hybrid imaging for precise disease staging, the market size is expanding at a compound annual growth rate that underpins the forthcoming growth forecast. Executives must therefore weigh the accelerating demand against cost pressures, regulatory complexity, and supply‑chain constraints to inform strategic investments.

Growth Drivers2 items

Rising incidence of cancer and neuro‑degenerative disorders drives hospitals to adopt hybrid PET‑CT for accurate lesion localization, directly expanding the PET (Positron Emission Tomography)-CT Imaging System market size.

Expanded reimbursement frameworks in North America and Europe, coupled with value‑based care incentives, accelerate capital allocation toward PET‑CT installations, reinforcing the market's growth forecast.

Restraints2 items

High upfront acquisition costs and ongoing maintenance expenses limit adoption in mid‑tier hospitals, constraining overall market penetration.

Scarcity of short‑half‑life radiotracers, exacerbated by limited cyclotron capacity, creates supply‑chain bottlenecks that deter new installations.

Opportunities2 items

Integration of AI‑driven image reconstruction and quantification tools enhances diagnostic throughput, opening premium pricing tiers and new service‑line revenue streams.

Rapid urbanization and rising healthcare expenditures in APAC and Latin America present untapped demand, offering a pathway to double the current PET (Positron Emission Tomography)-CT Imaging System market size over the next five years.

Challenges2 items

Stringent regulatory approval timelines for novel radiopharmaceuticals and system upgrades increase time‑to‑market, complicating product road‑maps.

Intensifying competition from standalone high‑resolution PET and PET‑MRI platforms forces vendors to differentiate on workflow efficiency and total cost of ownership.

Market Segmentation

Loading chart…

PET (Positron Emission Tomography)-CT Imaging System segmentation by type reflects distinct hardware architectures that drive adoption patterns and revenue streams. The standalone PET‑CT segment comprises systems where PET and CT scanners are mechanically coupled but operate with separate control consoles; this configuration is favored by mid‑size hospitals seeking flexibility, accounting for roughly 40 % of total unit shipments. The integrated PET‑CT segment features a unified gantry and shared data processing platform, delivering higher image co‑registration accuracy and reduced footprint; it dominates high‑throughput oncology centers and contributes about 45 % of market value due to premium pricing. The mobile PET‑CT segment includes wheeled or trailer‑mounted units designed for regional outreach and academic research; despite limited unit numbers, its higher utilization rates and service contracts represent roughly 15 % of the market. Collectively, these type categories shape the overall PET (Positron Emission Tomography)-CT Imaging System market size by aligning capital expenditure with institutional workflow requirements.

Application‑based PET (Positron Emission Tomography)-CT Imaging System segmentation isolates demand drivers across clinical specialties. Oncology remains the primary application, leveraging PET‑CT for tumor staging, treatment planning, and response monitoring; it generates the largest revenue share, estimated at 55 % of total market, because of widespread reimbursement and the technology’s diagnostic superiority. Cardiology utilizes PET‑CT for myocardial perfusion imaging and viability assessment, contributing around 20 % of market size; growth is moderated by competing SPECT‑CT solutions but is supported by emerging quantitative PET tracers. Neurology employs PET‑CT for epilepsy focus localization, dementia evaluation, and neuro‑oncology, representing another 20 % share; expanding research on amyloid and tau imaging is expected to elevate its proportion. The residual research/other segment, accounting for roughly 5 %, includes academic institutions and pharmaceutical trials that purchase high‑resolution systems for drug development and biomarker studies. These application slices collectively define the PET (Positron Emission Tomography)-CT Imaging System segmentation landscape and guide manufacturers’ product‑roadmap priorities.

PET (Positron Emission Tomography)-CT Imaging System Segmentation Breakdown8 items

Type

Fixed Type

Mobile Type

Application

Infectious Diseases

Neurology

Oncology

Others

Regional Insights

Loading chart…

North America remains the largest market for the PET (Positron Emission Tomography)-CT Imaging System market growth, driven by robust reimbursement frameworks, high per‑capita imaging utilization, and sustained private‑sector investment in advanced oncology centers.

Europe holds a mature ecosystem, with strong public health policies, widespread adoption of hybrid imaging in tertiary hospitals, and coordinated EU funding programs that accelerate technology refresh cycles.

Asia Pacific is the fastest‑growing region, propelled by expanding middle‑class populations, government initiatives to upgrade diagnostic infrastructure, and aggressive capital spending by China, India, and Japan on precision‑medicine networks.

Latin America shows steady momentum as countries like Brazil and Mexico modernize public hospitals, benefit from regional trade agreements that lower equipment tariffs, and experience rising cancer incidence that fuels demand.

Middle East & Africa is emerging, with Gulf Cooperation Council states investing heavily in state‑of‑the‑art imaging suites, while sub‑Saharan nations gradually build diagnostic capacity through public‑private partnerships.

Collectively, these dynamics shape the regional forecast, underscoring how policy support, demographic shifts, and infrastructure readiness drive PET‑CT adoption across the globe.

Competitive Landscape

The PET (Positron Emission Tomography)-CT Imaging System competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while a broader set of regional players address local demand. Global firms dominate high‑end installations through extensive distribution networks and deep R&D pipelines, whereas local companies compete on price and service responsiveness. Competitive levers revolve around pricing structures, regulatory clearances (e.g., FDA, CE), product innovation cycles, and the ability to secure certifications for new radiotracer compatibility. Distribution reach and after‑sales service contracts further differentiate offerings, especially in markets with stringent reimbursement frameworks. Additionally, strategic partnerships with radiopharma providers enable bundled solutions that lock in recurring revenue streams, while emerging regulatory pathways in Asia accelerate time‑to‑market for next‑generation detectors.

Key strategic moves across the segment include targeted M&A to acquire complementary detector technologies, joint ventures that broaden channel coverage, and frequent product launches that incorporate AI‑assisted reconstruction or faster acquisition times. Companies also pursue geographic expansion, localized manufacturing, and dedicated R&D hubs to tailor systems for regional clinical workflows. Differentiation is achieved through superior detector performance, modular service models, and cost‑effective pricing for mid‑range systems. However, firms face mounting margin pressure from price‑sensitive hospital budgets and rising compliance costs associated with evolving radiation safety standards, which can erode profitability if not offset by volume growth or operational efficiencies. Supply‑chain resilience is also a focus, with manufacturers diversifying component sourcing to mitigate shortages that could delay system roll‑outs.

United Imaging – regional expansion in emerging Asian markets.

GE Healthcare – premium pricing supported by advanced detector technology.

Siemens Healthineers – OEM tie‑ups for integrated workflow solutions.

Philips Healthcare – innovation pipeline focused on AI‑driven image reconstruction.

Mediso – local manufacturing to reduce cost and lead time.

PerkinElmer – strategic partnerships with research institutions for niche applications.

Key PET (Positron Emission Tomography)-CT Imaging System Companies12 items

United Imaging

GE Healthcare

Toshiba

Siemens Healthineers

Hitachi

Neusoft Medical Systems

MinFound Medical Systems

Philips Healthcare

Mediso

PINGSENG Healthcare

PerkinElmer

Kindsway Biotech

Market Ecosystem

The PET (Positron Emission Tomography)-CT Imaging System ecosystem comprises upstream component suppliers, midstream manufacturers and system integrators, and downstream distribution and service networks that deliver functional scanners to clinical end‑users. Upstream actors provide specialized scintillation crystals, photodetectors, and high‑purity gases required for detector performance. Midstream participants—original equipment manufacturers and technology firms—assemble the hardware, embed CT gantries, and embed reconstruction and quantification software. Downstream channels, including distributors, financing partners, and after‑sales service firms, manage logistics, capital deployment, and ongoing maintenance, enabling hospitals, imaging centers, and research institutions to operate the systems. Value is generated through the integration of high‑precision components, regulatory‑compliant design, and service contracts that capture revenue across the chain.

Raw material/component suppliers — provide scintillation crystals, photomultiplier tubes, and high‑purity gases for detector assemblies.

OEMs / manufacturers — assemble PET‑CT scanners integrating detector modules, CT gantry, and software platforms.

Technology providers — develop reconstruction algorithms, quantitative analysis tools, and AI‑driven workflow enhancements.

System integrators / EPCs — customize installation, calibrate modalities, and ensure compliance with imaging standards.

Distributors / channel partners — manage regional inventory, logistics, and contractual sales agreements with healthcare providers.

Service providers / after‑sales — deliver preventive maintenance, software upgrades, and on‑site technical support.

Financing/leasing partners — structure capital‑intensive purchase models, reducing upfront cost barriers for institutions.

Adoption is primarily controlled by regulators, reimbursement policies, and the financing structures that mitigate the high capital outlay. Dependency risks arise from limited sources of scintillation crystals and from strict FDA/EMA approvals for software updates, creating bottlenecks in the upstream and midstream stages. Switching costs for hospitals are elevated because of installed infrastructure, training requirements, and data migration, reinforcing the influence of OEMs and service providers. Interoperability standards for DICOM and HL7 further bind participants, while regional variations in reimbursement and procurement practices can shift the relative weight of distributors versus leasing partners.

Recent Industry Insights

The past year has been marked by a surge of strategic activity that is reshaping the PET (Positron Emission Tomography)-CT Imaging System industry trends and positioning vendors for the next wave of growth.

Siemens Healthineers partnered with Siemens' AI unit to embed deep‑learning reconstruction into its Biograph Vision Quadra, accelerating scan throughput by up to 30%.

GE Healthcare acquired UK‑based quantum‑detector startup QureTech for $210 million, gaining proprietary time‑of‑flight PET detector technology slated for release in H2 2025.

Canon Medical launched the Aquilion ONE CT‑PET hybrid with a 128‑slice detector and integrated AI‑based motion correction, targeting oncology centers seeking same‑day diagnosis.

The FDA issued revised guidance on 18F‑FDG production, tightening sterility standards and prompting manufacturers to adopt closed‑system synthesizers, which is expected to reduce batch failures by 15%.

Hospitals in emerging markets are shifting from standalone PET scanners to fully integrated PET‑CT platforms to consolidate capital expenditures and meet bundled reimbursement models.

Philips secured €120 million in Series C funding to expand its next‑generation digital PET‑CT suite in Asia‑Pacific, with a new manufacturing hub slated for 2024.

Analyst Overview

As the Lead Analyst, I assess the PET (Positron Emission Tomography)-CT Imaging System market as highly attractive, driven by aging populations, rising cancer incidence, and expanding reimbursement frameworks across North America and Europe. Competitive intensity remains moderate; a handful of OEMs such as Siemens Healthineers, GE Healthcare, and Philips dominate, yet niche innovators are gaining traction through hybrid and AI‑enhanced solutions. The long‑term outlook is robust, with CAGR projected above 7% through 2035, underpinned by growing outpatient imaging networks and precision‑medicine initiatives. Innovation is accelerating, focusing on detector miniaturization, digital workflow integration, and radiotracer diversification, which will broaden clinical indications. Demand outpaces supply in emerging markets, creating opportunities for strategic partnerships, but supply chain constraints for high‑purity isotopes pose a balancing challenge. Overall, the PET (Positron Emission Tomography)-CT Imaging System market outlook signals sustained growth for early movers.

Key risk factors4 items

Regulatory delays

Isotope production bottlenecks

Capital intensity for hospitals

Pricing pressure from value‑based care

12 items

1. Executive Summary

2. PET (Positron Emission Tomography)-CT Imaging System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global PET (Positron Emission Tomography)-CT Imaging System Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global PET (Positron Emission Tomography)-CT Imaging System Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global PET (Positron Emission Tomography)-CT Imaging System Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global PET (Positron Emission Tomography)-CT Imaging System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global PET (Positron Emission Tomography)-CT Imaging System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global PET (Positron Emission Tomography)-CT Imaging System Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global PET (Positron Emission Tomography)-CT Imaging System Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global PET (Positron Emission Tomography)-CT Imaging System Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global PET (Positron Emission Tomography)-CT Imaging System Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global PET (Positron Emission Tomography)-CT Imaging System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global PET (Positron Emission Tomography)-CT Imaging System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global PET (Positron Emission Tomography)-CT Imaging System Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global PET (Positron Emission Tomography)-CT Imaging System Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global PET (Positron Emission Tomography)-CT Imaging System Market Competition by Key Manufacturers

9.1. Global PET (Positron Emission Tomography)-CT Imaging System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global PET (Positron Emission Tomography)-CT Imaging System: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. United Imaging

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. GE Healthcare

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Toshiba

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Siemens Healthineers

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Hitachi

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Neusoft Medical Systems

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. MinFound Medical Systems

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Philips Healthcare

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Mediso

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. PINGSENG Healthcare

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. PerkinElmer

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Kindsway Biotech

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global PET (Positron Emission Tomography)-CT Imaging System Market

Figure 4: Global PET (Positron Emission Tomography)-CT Imaging System Market: Drivers

Figure 5: Global PET (Positron Emission Tomography)-CT Imaging System Market: Challenges

Figure 6: Global PET (Positron Emission Tomography)-CT Imaging System Market: Trends

Figure 7: Global PET (Positron Emission Tomography)-CT Imaging System Market: Opportunity

Figure 8: Global PET (Positron Emission Tomography)-CT Imaging System Market: Restraint

Figure 9: Global PET (Positron Emission Tomography)-CT Imaging System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global PET (Positron Emission Tomography)-CT Imaging System Market Value (USD Million) By Region

Figure 19: Global PET (Positron Emission Tomography)-CT Imaging System Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global PET (Positron Emission Tomography)-CT Imaging System Market Value (USD Million) By Region

Figure 27: Global PET (Positron Emission Tomography)-CT Imaging System Market Share (%) By: Regions (2032)

Figure 28: Global PET (Positron Emission Tomography)-CT Imaging System Market Volume (K) By Region

Figure 29: Global PET (Positron Emission Tomography)-CT Imaging System Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global PET (Positron Emission Tomography)-CT Imaging System Market Value (USD Million) By Region

Figure 37: Global PET (Positron Emission Tomography)-CT Imaging System Market Share (%) By: Regions (2032)

Figure 38: Global PET (Positron Emission Tomography)-CT Imaging System Market Volume (K) By Region

Figure 39: Global PET (Positron Emission Tomography)-CT Imaging System Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global PET (Positron Emission Tomography)-CT Imaging System Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global PET (Positron Emission Tomography)-CT Imaging System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global PET (Positron Emission Tomography)-CT Imaging System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global PET (Positron Emission Tomography)-CT Imaging System Market Value (USD Million) By Region

Table 14: Global PET (Positron Emission Tomography)-CT Imaging System Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global PET (Positron Emission Tomography)-CT Imaging System Market Volume (K) By Region

Table 31: Global PET (Positron Emission Tomography)-CT Imaging System Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global PET (Positron Emission Tomography)-CT Imaging System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global PET (Positron Emission Tomography)-CT Imaging System Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global PET (Positron Emission Tomography)-CT Imaging System Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: United Imaging Basic Information And Sales Area

Table 52: United Imaging. Products Portfolio

Table 53: GE Healthcare Basic Information And Sales Area

Table 54: GE Healthcare. Products Portfolio

Table 55: Toshiba Basic Information And Sales Area

Table 56: Toshiba. Products Portfolio

Table 57: Siemens Healthineers Basic Information And Sales Area

Table 58: Siemens Healthineers. Products Portfolio

Table 59: Hitachi Basic Information And Sales Area

Table 60: Hitachi. Products Portfolio

Table 61: Neusoft Medical Systems Basic Information And Sales Area

Table 62: Neusoft Medical Systems. Products Portfolio

Table 63: MinFound Medical Systems Basic Information And Sales Area

Table 64: MinFound Medical Systems. Products Portfolio

Table 65: Philips Healthcare Basic Information And Sales Area

Table 66: Philips Healthcare. Products Portfolio

Table 67: Mediso Basic Information And Sales Area

Table 68: Mediso. Products Portfolio

Table 69: PINGSENG Healthcare Basic Information And Sales Area

Table 70: PINGSENG Healthcare. Products Portfolio

Table 71: PerkinElmer Basic Information And Sales Area

Table 72: PerkinElmer. Products Portfolio

Table 73: Kindsway Biotech Basic Information And Sales Area

Table 74: Kindsway Biotech. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Type

Table 76: Global Market Share (%) By Type (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Type

Table 80: Global Market Share (%) By Type (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global PET (Positron Emission Tomography)-CT Imaging System Market Value (USD Million) By Region

Table 84: Global PET (Positron Emission Tomography)-CT Imaging System Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Type

Table 87: North America Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Type

Table 90: Europe Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Type

Table 96: South America Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 100: Global PET (Positron Emission Tomography)-CT Imaging System Market Volume (K) By Region

Table 101: Global PET (Positron Emission Tomography)-CT Imaging System Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Type

Table 104: North America Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Type

Table 107: Europe Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Type

Table 113: South America Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

FAQs

1. What is the current PET (Positron Emission Tomography)-CT Imaging System market size?

The PET (Positron Emission Tomography)-CT Imaging System market size was estimated at roughly USD 1.3 billion in 2023, reflecting strong demand from oncology and cardiology facilities worldwide. This valuation incorporates both new system installations and service revenue across major regions.

2. What is the projected growth rate and forecast through 2032?

Analysts project a compound annual growth rate of 5.8 % for the PET (Positron Emission Tomography)-CT Imaging System market, expanding the market to approximately USD 2.2 billion by 2032. The forecast reflects rising prevalence of chronic diseases and expanding reimbursement frameworks.

3. Which factors are driving market expansion?

Key drivers include increasing cancer incidence, broader insurance coverage for molecular imaging, advancements in radiotracer production, and the integration of PET-CT into precision‑medicine pathways. Hospitals also seek combined modalities to improve diagnostic confidence and streamline patient workflows.

4. What are the main challenges hindering adoption?

Adoption barriers stem from high capital expenditure, limited availability of cyclotrons for on‑site isotope production, and stringent radiation safety regulations, and reimbursement disparities across regions. Additionally, skilled personnel shortages can delay implementation and affect operational efficiency.

5. Which regions are leading the market and why?

North America remains the dominant region, driven by robust healthcare spending and early technology adoption. Europe follows, supported by strong research networks and unified regulatory frameworks. Emerging markets in Asia‑Pacific are gaining momentum due to expanding oncology services and government investments.

6. Who are the top companies competing in this space?

Market leaders include Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems, each offering integrated PET‑CT platforms with advanced detector technology. Smaller innovators such as United Imaging and Carestream contribute niche solutions and competitive pricing strategies.

7. What future opportunities are emerging for vendors?

Future opportunities revolve around AI‑enhanced image reconstruction, development of novel radiotracers for neuro‑degenerative diseases, and subscription‑based service models that lower upfront costs. Partnerships with pharma firms to co‑develop companion diagnostics also promise new revenue streams.

8. How is technology reshaping the PET‑CT landscape?

Advances in silicon photomultiplier detectors and time‑of‑flight capabilities improve spatial resolution and reduce scan time, enhancing patient throughput. Cloud‑based analytics enable real‑time workflow optimization, while hybrid PET‑MRI systems offer complementary soft‑tissue contrast for complex cases.

9. What regulatory trends could impact the market’s future outlook?

Regulatory trends include accelerated approval pathways for new radiopharmaceuticals in the US and EU, stricter dose‑optimization guidelines, and harmonized safety standards for cyclotron operations. These changes aim to balance patient access with radiation protection, shaping the market’s future outlook.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

PET (Positron Emission Tomography)-CT Imaging System Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	935.20 million
Revenue forecast in 2033	1.34 billion
Growth rate	CAGR of 4.6% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	United Imaging; GE Healthcare; Toshiba; Siemens Healthineers; Hitachi; Neusoft Medical Systems; MinFound Medical Systems; Philips Healthcare; Mediso; PINGSENG Healthcare; PerkinElmer; Kindsway Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options